Quarterly report pursuant to Section 13 or 15(d)

Fair Value of Financial Instruments (Tables)

v3.24.1.1.u2
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Investments, All Other Investments [Abstract]  
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis

The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balance sheet as of March 31, 2024 and December 31, 2023, respectively:

  

    Level 1     Level 2     Level 3  
    Fair Value Measurements at March 31, 2024  
    Level 1     Level 2     Level 3  
Assets                  
Cash   $ 40,648     $ -     $ -  
Total assets     40,648       -       -  
Liabilities                        
Notes payable, related parties, net of $9,729 of debt discounts     -       2,441,252       -  
Notes payable, net of $126,670 of debt discounts     -       268,330       -  
Total liabilities     -       (2,709,582 )     -  
Fair Value, Net Asset (Liability)   $ 40,648     $ (2,709,582 )   $ -  

 

    Level 1     Level 2     Level 3  
    Fair Value Measurements at December 31, 2023  
    Level 1     Level 2     Level 3  
Assets                  
Cash   $ 726     $ -     $ -  
Total assets     726       -       -  
Liabilities                        
                         
Convertible notes payable, related party     -       750,000       -  
Notes payable, related parties     -       1,146,500       -  
Notes payable, net of $24,136 of debt discounts     -       310,864       -  
Total liabilities     -       (2,207,364 )     -  
Fair Value, Net Asset (Liability)   $ 726     $ (2,207,364 )   $ -